Clinical Research Directory
Browse clinical research sites, groups, and studies.
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
Sponsor: Centre Henri Becquerel
Summary
The aim of our study is to find the best imaging technique, alone or in combination, that can best predict a complete response (absence of tumour cells). It also seems important to identify blood markers able to predict which patients will benefit most from treatment, with a view to personalising them, or which patients will be most at risk of toxicities, particularly related to immunotherapy, with a view to personalising monitoring.
Official title: Quadrimodal Radiological Prediction (Ultrasound, Angiography/Mammography, Magnetic Rsonance Imaging, Positron Emission Tomography-computed Tomgraphy Scan) of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
115
Start Date
2025-05-28
Completion Date
2029-11-28
Last Updated
2026-01-02
Healthy Volunteers
No
Conditions
Interventions
Imaging assessment
The patient will have four imaging exam : Ultrasound, angio/mammography, MRI and PET-scan
Locations (1)
Centre Henri Becquerel
Rouen, France